Eric Weaver

Eric Weaver serves as a Professor in the School of Biological Sciences at the University of Nebraska-Lincoln, based in MOLR 234, Lincoln, NE 68583-0900. His research program bridges bioinformatics, phylogenetics, immunology, and molecular biology to advance vaccine development against microbial pathogens.

His academic foundation includes:

• Ph.D. in Genetics from Texas A&M University (2002-2005), thesis: 'Phylogenetic Analysis of Feline Immunodeficiency Virus and the Development of a Mucosal Prophylactic Vaccine' (Mentor: Ellen Collisson)
• M.S. in Virology/Immunology from Texas State University (1997), thesis: 'Synergistic Antiviral Inhibition of Newcastle Disease virus and Influenza A Virus' (Mentor: Gary Aron)
• B.S. in Microbiology from Texas State University (1995)
• NIH T32 Postdoctoral Fellowship at Duke University Medical Center, Human Vaccine Institute (2002-2005), project: 'A Universal Env Immunogen for all HIV-1 Subtypes' (Mentor: Feng Gao)

Dr. Weaver's research operates through two synergistic frameworks:

• Vaccine Antigen Design: Testing ancestral/centralized genes for universal vaccine applications and leveraging systems biology to enhance antigen breadth and efficacy
• Vaccine Platform Design: Developing safer viral vectors and novel vaccine platforms through alternative viral vector exploration

His work targets fundamental host-pathogen interaction mechanisms to create broadly effective antimicrobial vaccines.

Dr. Weaver maintains an active research program supported by institutional resources, with scholarly output accessible via PubMed and Google Scholar. His laboratory focuses on translational approaches to vaccine innovation, emphasizing practical solutions for infectious disease prevention.